Reol27®
The optimal solution for preventing and treating iron-deficiency anemia and depleted iron stores
Reol27® is an innovative, patented iron supplement whose active ingredient is elemental Reolin™ iron (Fe⁰), sourced from raw materials certified GRAS (Generally Recognized As Safe) by the U.S. FDA.
Reol Folat
Reol Folate® is an advanced oral hematinic formulation containing zero‑valent elemental iron (Fe⁰) with high elemental iron content and excellent gastrointestinal tolerability, complemented by folate and vitamin B12 as essential cofactors in erythropoiesis. Zero‑valent iron provides controlled and efficient iron absorption with minimal oxidative stress and reduced interaction with gastrointestinal microbiota, while folate and vitamin B12 support DNA synthesis, red blood cell maturation, and effective hemoglobin production. This rational combination ensures a comprehensive approach to anemia management by addressing both iron availability and functional erythropoietic requirements.
Reol Folate® 27 mg with Folate and Vitamin B12 is indicated for the prevention and treatment of iron deficiency anemia and mixed nutritional anemias, particularly in individuals with increased hematopoietic demand or combined micronutrient deficiencies, including women of reproductive age, pregnancy and lactation, adolescents, and patients with chronic or functional anemia. Its favorable safety and tolerability profile makes it suitable for long‑term supplementation and for patients intolerant to conventional iron salts, while supporting optimal correction of hemoglobin levels and restoration of iron stores
Reol C 27
Reol C® 27 is an advanced oral iron formulation containing zero‑valent elemental iron (Fe⁰) with high elemental iron content and superior gastrointestinal tolerability. The addition of vitamin C enhances iron absorption by maintaining iron in a reduced, bioavailable state and facilitating its transport across the intestinal epithelium, thereby optimizing systemic iron uptake. This synergistic combination allows effective iron repletion with minimal oxidative stress, reduced interaction with gastrointestinal microflora, and a lower incidence of common iron‑related adverse effects such as nausea, abdominal discomfort, and constipation.
Reol C® 27 mg with Vitamin C is indicated for the prevention and treatment of iron deficiency and iron deficiency anemia, particularly in populations with increased iron requirements or impaired absorption, including women of reproductive age, pregnancy and postpartum periods, adolescents, and patients with chronic or functional iron deficiency. Its favorable safety and tolerability profile makes it suitable for long‑term supplementation and for patients who are intolerant to conventional iron salts, while ensuring efficient correction of iron stores and hemoglobin levels.
Reol 27®
Five exclusive patented features:
- Optimized Particle Size: 8.5 µm — specifically designed for maximum uptake via DMT1 and TFR1 receptors in the duodenum.
- Spherical Particle Geometry: Enhances flowability and uniform distribution throughout the GI tract.
- Uniform Particle Dimensions: Stable absorption and predictable release profile.
- Smooth, Polished Surface: Reduces mucosal irritation and optimizes contact with absorptive surfaces.
- Slow‑Release with 69% Bioavailability: Increases efficiency and minimizes accumulation of unusable iron.
Reolin a True Devotion to Healing.
Reol 27® – Specifically Tailored for Pregnancy and Special Life Stages
Reol 27® mg is precisely formulated to meet the World Health Organization’s recommended daily iron intake for pregnant women. Each tablet contains 27 mg elemental Reolin™ iron (Fe⁰) — ideal for conditions with elevated iron requirements.
Scientific & Clinical Benefits of Reol 27®
- Patented Reolin™ Formulation: Optimized particle size (8.5 µm) and complete uniformity deliver 69% bioavailability with gradual GI release.
- Superior Tolerability: No metallic taste, minimal GI discomfort, markedly reduced constipation and bloating compared to iron salts.
- Not inhibited by Hepcidin: Effective absorption in inflammatory or chronic diseases.
- Compact, Easy-to-Swallow Tablet: Enhanced patient compliance, even among elderly or patients with swallowing difficulties.
- Designed for Pregnancy:
- One tablet daily meets WHO iron requirement.
- Does not cause bloating, heartburn, or trigger nausea/gag reflex.
Indications for Reol 27®
- Iron supplementation during pregnancy (primary indication)
- Iron-deficiency anemia with high daily requirements
- Postpartum iron replenishment
- Support in heavy menstrual bleeding
Safety Profile
- LD₅₀ = 50,000 mg — extremely high margin of safety
- GRAS FDA-certified source material
- Minimal residual intestinal iron — reduced overdose risk
- Safe for long-term use across all age groups
Reol 27®
£28.99
The optimal solution for preventing and treating iron-deficiency anemia and depleted iron stores
Reol® is an innovative, patented iron supplement whose active ingredient is elemental Reolin™ iron (Fe⁰), sourced from raw materials certified GRAS (Generally Recognized As Safe) by the U.S. FDA.
Description
Key Features & Benefits
- Exceptional Bioavailability: Up to 69% absorption of iron in the human body.
- Slow-Release Formulation: Gradual iron release from the gastrointestinal tract to minimize irritation and enhance tolerability.
- Reduced Toxicity & Side Effects: Lower risks from free iron and fewer gastrointestinal adverse events.
- Extended Intervention Window in Overdose: Significantly reduced risk in accidental excessive intake.
- Not Inhibited by Hepcidin: Maintains effective absorption even under inflammatory conditions or increased physiological demand.
Scientific Advantages of Reolin™ (Fe⁰)
Five exclusive patented features:
- Optimized Particle Size: 8.5 µm — specifically designed for maximum uptake via DMT1 and TFR1 receptors in the duodenum.
- Spherical Particle Geometry: Enhances flowability and uniform distribution throughout the GI tract.
- Uniform Particle Dimensions: Stable absorption and predictable release profile.
- Smooth, Polished Surface: Reduces mucosal irritation and optimizes contact with absorptive surfaces.
- Slow‑Release with 69% Bioavailability: Increases efficiency and minimizes accumulation of unusable iron.
Medical Indications of Reol®
(Elemental Reolin™ Iron — Slow Release, High Safety Margin)
- Prevention and treatment of iron-deficiency anemia in all age groups.
- Pregnant & Lactating Women: Meets WHO daily iron requirement for maternal and fetal health
- Gastrointestinal disorders: suitable and well tolerated even in patients with IBS due to minimal constipation
- Children & Adolescents: Ideal for long-term maintenance dosage.3
- Iron deficiency associated with blood loss or chronic diseases (e.g., chronic kidney disease, inflammatory disorders, hematologic conditions).
- High-demand situations: rapid growth, adolescence, intensive sports, or medically increased iron demands.
- Nutritional support in poor absorption states: chronic GI diseases (ulcerative colitis, Crohn’s disease), GI cancers, and post‑gastrectomy/resection patients.
High Safety for Long‑Term Use
- Slow‑release prevents sudden peaks in free iron concentration.
- LD₅₀ = 50,000 mg — extremely high safety margin, suitable for pediatric and elderly use.
- Minimal unabsorbed iron in the intestine — reduces overdose risk and free iron accumulation.
- No increased risk of sepsis: Gradual release avoids promoting pathogenic bacterial growth, lowering systemic infection risk.
- Appropriate for vulnerable groups: children, pregnant women, elderly patients, chronically ill individuals, and immunocompromised persons.
Reol® 27 – Specifically Tailored for Pregnancy and Special Life Stages
Reol® 27 mg is precisely formulated to meet the World Health Organization’s recommended daily iron intake for pregnant women. Each tablet contains 27 mg elemental Reolin™ iron (Fe⁰) — ideal for conditions with elevated iron requirements.
Scientific & Clinical Benefits of Reol® 27
- Patented Reolin™ Formulation: Optimized particle size (8.5 µm) and complete uniformity deliver 69% bioavailability with gradual GI release.
- Superior Tolerability: No metallic taste, minimal GI discomfort, markedly reduced constipation and bloating compared to iron salts.
- Not inhibited by Hepcidin: Effective absorption in inflammatory or chronic diseases.
- Compact, Easy-to-Swallow Tablet: Enhanced patient compliance, even among elderly or patients with swallowing difficulties.
- Designed for Pregnancy:
- One tablet daily meets WHO iron requirement.
- Does not cause bloating, heartburn, or trigger nausea/gag reflex.
Indications for Reol® 27
- Iron supplementation during pregnancy (primary indication)
- Iron-deficiency anemia with high daily requirements
- Postpartum iron replenishment
- Support in heavy menstrual bleeding
Safety Profile
- LD₅₀ = 50,000 mg — extremely high margin of safety
- GRAS FDA-certified source material
- Minimal residual intestinal iron — reduced overdose risk
- Safe for long-term use across all age groups
Related products
Reol®
£24.99
Reol® Tablets
Reol is an innovative patent containing in its composition reolin iron Fe. All components in the preparation are certified GRAS
Description
Reol ®
| Reol elemental iron, effectively prevents iron deficiency & anemia |
Reol ® contains Reolin elemental iron , which :
- has a high iron content exceeding 98%
- has very high level bioavailability
- has a safety certificate of GRAS (Generally recognized as safe )
Reol ® tablet is intended for Adults
- does not cause stomach ache , vomiting diarrhea and constipation
- does not distrub the intestinal microflora
- no metallic aftertaste
Active ingredients :
- Each tablet contains 18mg Reolin
- Elemental iron
Recommended dosage :
- take 1 tablet daily
Reviews
There are no reviews yet.
Reviews
There are no reviews yet.